Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Biol Pharm Bull ; 41(12): 1757-1768, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-30504678

RESUMO

The pentacyclic triterpenoid ursolic acid was previously shown to inhibit the intracellular trafficking of intercellular adhesion molecule-1 (ICAM-1) from the endoplasmic reticulum (ER) to the Golgi apparatus. In the present study, we further investigated the biological activities of three pentacyclic triterpenoids closely related to ursolic acid on the interleukin 1α-induced expression and intracellular trafficking of ICAM-1. In human lung adenocarcinoma A549 cells, asiatic acid, corosolic acid, and maslinic acid interfered with the intracellular transport of ICAM-1 to the cell surface. Endoglycosidase H-sensitive glycans were linked to ICAM-1 in asiatic acid-, corosolic acid-, and maslinic acid-treated cells. Unlike corosolic acid, asiatic acid and maslinic acid increased the amount of the ICAM-1 protein. Moreover, asiatic acid increased the co-localization of ICAM-1 with calnexin (an ER marker), but not GM130 (a cis-Golgi marker). Asiatic acid, corosolic acid, and maslinic acid inhibited yeast α-glucosidase activity, but not Jack bean α-mannosidase activity. These results indicate that asiatic acid, corosolic acid, and maslinic acid interfere with the intracellular transport of ICAM-1 to the cell surface and cause the accumulation of ICAM-1 linked to endoglycosidase H-sensitive glycans.


Assuntos
Retículo Endoplasmático/metabolismo , Glicosilação/efeitos dos fármacos , Complexo de Golgi/metabolismo , Molécula 1 de Adesão Intercelular/metabolismo , Triterpenos Pentacíclicos/farmacologia , Triterpenos/farmacologia , Células A549 , Citocinas/imunologia , Retículo Endoplasmático/efeitos dos fármacos , Retículo Endoplasmático/imunologia , Complexo de Golgi/efeitos dos fármacos , Complexo de Golgi/imunologia , Humanos , Molécula 1 de Adesão Intercelular/genética , Microscopia Confocal , Polissacarídeos/metabolismo , Transporte Proteico
2.
Int J Mol Sci ; 18(12)2017 Dec 02.
Artigo em Inglês | MEDLINE | ID: mdl-29207489

RESUMO

Quinacrine has been used for therapeutic drugs in some clinical settings. In the present study, we demonstrated that quinacrine decreased the expression of intercellular adhesion molecule-1 (ICAM-1) induced by tumor necrosis factor (TNF)-α and interleukin-1 (IL-1) α in human lung adenocarcinoma A549 cells. Quinacrine inhibited ICAM-1 mRNA expression and nuclear factor κB (NF-κB)-responsive luciferase reporter activity following a treatment with TNF-α and IL-1α. In the NF-κB signaling pathway, quinacrine did not markedly affect the TNF-α-induced degradation of the inhibitor of NF-κB or the TNF-α-induced phosphorylation of the NF-κB subunit, p65, at Ser-536 and its subsequent translocation to the nucleus. In contrast, a chromatin immunoprecipitation assay showed that quinacrine prevented the binding of p65 to the ICAM-1 promoter following TNF-α stimulation. Moreover, TNF-α and the Fas ligand effectively reduced the viability of A549 cells in the presence of quinacrine only. Quinacrine down-regulated the constitutive and TNF-α-induced expression of c-FLIP and Mcl-1 in A549 cells. These results revealed that quinacrine inhibits ICAM-1 transcription by blocking the DNA binding of p65 and sensitizes A549 cells to TNF-α and the Fas ligand.


Assuntos
Adenocarcinoma/genética , Antineoplásicos/farmacologia , Molécula 1 de Adesão Intercelular/genética , Neoplasias Pulmonares/genética , Quinacrina/farmacologia , Fator de Transcrição RelA/metabolismo , Transcrição Gênica/efeitos dos fármacos , Células A549 , Adenocarcinoma/tratamento farmacológico , Adenocarcinoma/metabolismo , Adenocarcinoma de Pulmão , Proliferação de Células/efeitos dos fármacos , Sobrevivência Celular/efeitos dos fármacos , Sinergismo Farmacológico , Proteína Ligante Fas/farmacologia , Regulação Neoplásica da Expressão Gênica/efeitos dos fármacos , Humanos , Molécula 1 de Adesão Intercelular/metabolismo , Neoplasias Pulmonares/tratamento farmacológico , Neoplasias Pulmonares/metabolismo , Regiões Promotoras Genéticas/efeitos dos fármacos , Transdução de Sinais/efeitos dos fármacos , Fator de Necrose Tumoral alfa/farmacologia
3.
Eur J Pharmacol ; 767: 126-34, 2015 Nov 15.
Artigo em Inglês | MEDLINE | ID: mdl-26460147

RESUMO

Betulinic acid (3ß-hydroxy-20(29)-lupen-28-oic acid), oleanolic acid (3ß-hydroxy-olean-12-en-28-oic acid), and ursolic acid (3ß-hydroxy-urs-12-en-28-oic acid) are close structural isomers of natural pentacyclic triterpenoid carboxylic acids. We recently identified a unique biological effect of ursolic acid, its inhibition of the intracellular trafficking of glycoproteins. In the present study, we demonstrated that betulinic acid and oleanolic acid did not inhibit the interleukin-1α-induced expression of cell-surface intercellular adhesion molecule-1 (ICAM-1) in human lung carcinoma A549 cells. Nevertheless, betulinic acid and, to a lesser extent, oleanolic acid interfered with N-linked glycan modifications to ICAM-1 in a similar manner to castanospermine (an inhibitor of endoplasmic reticulum α-glucosidases I and II), but not swainsonine (an inhibitor of Golgi α-mannosidase II). Consistent with these results, betulinic acid and oleanolic acid inhibited yeast α-glucosidase activity, but not Jack bean α-mannosidase activity. Thus, to the best of our knowledge, this is the first study to show that betulinic acid and oleanolic acid interfere with N-linked glycan modifications to ICAM-1, but not its intracellular transport to the cell surface.


Assuntos
Inibidores de Glicosídeo Hidrolases/farmacologia , Molécula 1 de Adesão Intercelular/metabolismo , Ácido Oleanólico/farmacologia , Triterpenos/farmacologia , Linhagem Celular Tumoral , Humanos , Indolizinas/farmacologia , Molécula 1 de Adesão Intercelular/biossíntese , Interleucina-1alfa/farmacologia , Triterpenos Pentacíclicos , Transporte Proteico/efeitos dos fármacos , Swainsonina/farmacologia , alfa-Manosidase/antagonistas & inibidores , Ácido Betulínico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...